Nyumbani › Multiple Myeloma › Iowa › Cedar Rapids
Majaribio ya kliniki ya Multiple Myeloma katika Cedar Rapids, IA
Masomo 15 ya Multiple Myeloma yanatafuta washiriki katika vituo vya Cedar Rapids na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
InaajiriHatua 3
- University of Iowa Hospitals and Clinics, Iowa City · Mi 25 mbali
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
InaajiriHatua 1
- Research Site, Iowa City · Mi 25 mbali
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
InaajiriHatua 3
- University of Iowa Hospital and Clinics, Iowa City · Mi 25 mbali
Collection of Tissue Samples for Cancer Research
InaajiriUtafiti wa uchunguzi
- University of Iowa, Iowa City · Mi 25 mbali
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
InaajiriHatua 2
- University of Iowa, Iowa City · Mi 25 mbali
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
InaajiriHatua 3
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
InaajiriHatua 1/2
- Research Site, Iowa City · Mi 25 mbali
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
InaajiriHatua 3
- Research Site, Iowa City · Mi 25 mbali
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
InaajiriHatua 2
- University of Iowa, Iowa City · Mi 25 mbali
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
InaajiriHatua 3
- Physicians' Clinic of Iowa PC, Cedar Rapids
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · Mi 25 mbali
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
InaajiriHatua 2
- University of Iowa, Iowa City · Mi 25 mbali
Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma
InaajiriHatua 1
- University of Iowa Health Care, Iowa City · Mi 25 mbali
Sleep Apnea in Patients With MGUS and MM
InaajiriUtafiti wa uchunguzi
- University of Iowa, Iowa City · Mi 25 mbali
Activity Levels in Bone Marrow Transplant Patients
InaajiriUtafiti wa uchunguzi
- University of Iowa, Iowa City · Mi 25 mbali
Limited-duration Teclistamab
InaajiriHatua 2
- University of Iowa Hospitals and Clinics, Iowa City · Mi 25 mbali
Majaribio ya Multiple Myeloma katika miji mingine
- New York City, NYUtafiti 60
- Boston, MAUtafiti 42
- Atlanta, GAUtafiti 41
- Houston, TXUtafiti 38
- Durham, NCUtafiti 37
- Nashville, TNUtafiti 32
- Denver, COUtafiti 27
- Rochester, MNUtafiti 24
- St. Louis, MOUtafiti 24
- Columbus, OHUtafiti 24
- Baldwin Park, CAUtafiti 23
- Chicago, ILUtafiti 22
Masomo mengine katika Cedar Rapids
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 20
- Saratani ya MatitiUtafiti 17
- Leukemia ya Myeloid ya GhaflaUtafiti 16
- Saratani (aina zote)Utafiti 15
- Saratan ya MapafuUtafiti 14
- Kansari ya kolorektaliUtafiti 13
- Saratani ya ProstateUtafiti 12
- Kansari ya Seluli za Skwamu za Kichwa na ShingoUtafiti 12
- MelanomaUtafiti 10
- KigonjwaUtafiti 10
- Saratani ya MetastasiUtafiti 9
- Saratani ya EndometrialUtafiti 9
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.